SELLAS Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a definitive leukemia vaccine, but another game changer – personalized cancer vaccines – could be on the horizon thanks to artificial intelligence.
“I think it’s going to be a revolutionary decade in medicine and in clinical research,” he said Thursday on “Fox & Friends.”
“Where AI comes into play is where it will allow us to do things quickly, and it will become more personal. In other words, if you have a patient with cancer, we can use AI to do a genomic sequencing and with the results we can then create a specific vaccine or a specific treatment, or we can say this specific treatment for the patient will work.”
AI is expected to revolutionize cancer treatments in the coming years. (iStock)
How long will it take for the technology to develop? Stergiou predicts the first of the specialized vaccines could arrive within the next three to four years.
“It’s really important to understand that if you put garbage into this algorithm, you’re going to get garbage out of it, so it’s going to take a lot of effort from the medical community to really fit that data set appropriately, and it’s going to be a be an ongoing process.” evolutionary thing.”
AI expert and “Some Future Day” author Mark Beckman, who also joined “Fox & Friends” on Thursday, calls the AI revolution the “age of imagination.”
AI CAN PREDICT WHETHER CANCER TREATMENTS WILL WORK, EXPERTS SAY: ‘TENSIVE TIME IN MEDICINE’
Speaking to the presenters on the round bench, he noted Google’s new AI research system, AMIE, which is designed to help detect rare diseases and serve as a co-pilot for doctors.
“They’ve done some research and the ability to do that discover these rare diseases and diseases are now at a very high level, so doctors will use that as a tool to help diagnose them.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
